Harvard Bioscience, Inc. Financial Ratios — HBIO Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	3.03	1.82	-1.36	1.74	-14.88	-3.78	-0.8	-2.1	-2.81	-4.86	-0.18	-6.19	-2.42	-9.4	-54.86
Return on Capital (%)	-6.86	-4.34	- -	-4.1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	6.19	4.63	- -	3.09	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	46.11	47.08	45.35	45.41	44.84	46.32	50.6	52.31	55.37	56.85	56.9	53.66	58.86	58.18	57.67
EBITDA Margin (%)	12.13	11.11	7.3	9.86	3.36	3	4.09	7.32	8.24	7.69	8.15	0.36	7.92	1	6.98
Operating Margin (%)	8.15	7.32	3.51	6.29	-0.85	-1.09	-0.82	0.81	1.58	0.22	1.74	-6.32	1.69	-6.6	0.12
Incremental Operating Margin (%)	-269.2	-31.73	74.22	90.15	- -	- -	- -	3.73	-18.55	11.48	10.98	- -	-835.02	- -	-83.2
Pretax Margin (%)	6.31	6.2	0.41	4.06	-3.32	-2.94	-3.39	-6.6	-4.74	-7.14	-0.12	-8.1	-2.28	-12.39	-66.3
Profit Margin (%)	3.5	2.13	-1.74	2.17	-17.52	-4.12	-1.12	-2.42	-4.03	-7.65	-0.24	-8.4	-3.04	-13.18	-65.51
Net Income to Common Margin (%)	3.5	2.13	-1.74	2.17	-17.52	-4.12	-1.12	-2.42	-4.03	-7.65	-0.24	-8.4	-3.04	-13.18	-65.51
Effective Tax Rate (%)	22.99	34.79	- -	46.68	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	16	13	25	21	19	14	12	61	64	58	57	54	43	44	44
ST Debt	- -	- -	5	5	2	2	3	6	9	4	5	6	7	38	2
LT Debt	16	13	20	16	16	11	9	55	55	54	52	48	35	6	43
Total Debt/EBITDA	1.23	1.05	3.22	2	5.14	4.38	3.71	6.88	6.74	7.33	5.88	132.62	4.81	47.03	7.32
Net Debt/EBITDA	-0.12	-0.63	-0.13	0.68	3.29	2.6	2.07	5.95	4.75	5.05	4.18	103.46	3.63	34.72	4.51
Total Debt/EBIT	1.84	1.59	6.71	3.14	-20.25	-12.11	-18.5	61.78	35.09	260.63	27.57	-7.57	22.58	-7.16	442.77
Net Debt/EBIT	-0.18	-0.95	-0.28	1.07	-12.96	-7.18	-10.32	53.48	24.76	179.59	19.61	-5.91	17.04	-5.29	272.56
EBITDA to Interest Expense	17.55	21.14	8.04	10.82	4.31	4.91	4.44	1.65	1.77	1.63	6.29	0.16	2.48	0.27	1.23
EBITDA-CapEx/Interest Expense	15.22	18.01	6.28	8.8	0.79	2.6	3.14	1.46	1.54	1.34	5.42	-0.46	1.98	-0.48	0.97
EBIT to Interest Expense	11.8	13.94	3.86	6.9	-1.09	-1.78	-0.89	0.18	0.34	0.05	1.34	-2.81	0.53	-1.76	0.02
Interest Expense	1	1	1	1	1	1	1	5	5	5	2	3	4	4	5
Common Equity/Total Assets	-62.6	-57.6	-69.87	-67.9	-92.72	-107.28	-106.58	-70.84	-75.29	-84.44	-81.45	-97.51	-105.68	-124.42	-267.59
Long-Term Debt/Equity (%)	17.07	12.43	20.9	17.23	21.09	15.75	11.1	66.26	67.5	70.12	61.85	66.87	48.58	10.07	311.29
Long-Term Debt/Capital (%)	-25.89	-20.25	-28.26	-23.22	-17.68	-11.17	-8.57	-93.45	-92.41	-72.32	-68.54	-55.2	-34.67	-5.64	-25.15
Long-Term Debt/Total Assets (%)	12.87	9.7	14.58	12.1	13.64	10.55	8.21	32.51	33.45	34.41	31.77	33.22	25.84	5.04	53.39
Total Debt/Equity (%)	17.07	12.43	26.19	22.47	24.14	19.04	14.52	73.49	78.91	75.12	68.3	75.11	58.53	70.25	322.39
Total Debt/Capital (%)	-25.89	-20.25	-35.41	-30.28	-20.24	-13.49	-11.21	-103.64	-108.03	-77.48	-75.68	-61.99	-41.77	-39.35	-26.05
Total Debt/Total Assets (%)	12.87	9.7	18.27	15.78	15.6	12.76	10.74	36.06	39.1	36.86	35.09	37.31	31.14	35.13	55.3
Net Debt to Equity	-1.69	-7.42	-1.08	7.66	15.45	11.29	8.1	63.61	55.67	51.76	48.57	58.59	44.17	51.86	198.46
Net Debt/Capital (%)	2	9.14	1.07	-8.61	-12.07	-7.58	-5.96	-78.74	-66.88	-48.02	-48.76	-45.99	-30.26	-28.03	-15.26
EBITDA	13	12	8	11	4	3	3	9	10	8	10	- -	9	1	6
EBITDA-CapEx	11	11	6	9	1	2	2	8	8	6	8	-1	7	-2	5
Operating Income (Loss)	9	8	4	7	-1	-1	-1	1	2	- -	2	-7	2	-6	- -

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.87	2.09	1.6	0.78	0.35	0.38	0.37	0.32	0.33	0.4	0.31	0.19	0.16	0.07	0.39
Current Ratio	6.02	5.96	3.78	3.15	2.62	3.11	3.39	2.27	2.12	2.46	2.43	2.2	1.85	0.82	2.2
Quick Ratio	3.71	4.01	2.7	1.93	1.46	1.75	1.59	1.16	1.15	1.24	1.17	0.91	0.77	0.35	1.12
CFO/Avg Current Liab	0.64	0.83	0.31	0.25	0.04	0.32	0.07	0.15	0.32	0.4	0.05	0.05	0.56	0.04	0.17
Common Equity/Total Assets	-62.6	-57.6	-69.87	-67.9	-92.72	-107.28	-106.58	-70.84	-75.29	-84.44	-81.45	-97.51	-105.68	-124.42	-267.59
Long-Term Debt/Equity (%)	17.07	12.43	20.9	17.23	21.09	15.75	11.1	66.26	67.5	70.12	61.85	66.87	48.58	10.07	311.29
Long-Term Debt/Capital (%)	-25.89	-20.25	-28.26	-23.22	-17.68	-11.17	-8.57	-93.45	-92.41	-72.32	-68.54	-55.2	-34.67	-5.64	-25.15
Long-Term Debt/Total Assets (%)	12.87	9.7	14.58	12.1	13.64	10.55	8.21	32.51	33.45	34.41	31.77	33.22	25.84	5.04	53.39
Total Debt/Equity (%)	17.07	12.43	26.19	22.47	24.14	19.04	14.52	73.49	78.91	75.12	68.3	75.11	58.53	70.25	322.39
Total Debt/Capital (%)	-25.89	-20.25	-35.41	-30.28	-20.24	-13.49	-11.21	-103.64	-108.03	-77.48	-75.68	-61.99	-41.77	-39.35	-26.05
Total Debt/Total Assets (%)	12.87	9.7	18.27	15.78	15.6	12.76	10.74	36.06	39.1	36.86	35.09	37.31	31.14	35.13	55.3
CFO/Total Liabilities	21.35	27.54	9.91	10.76	1.66	15.13	3.71	3.36	9.67	11.73	1.6	1.58	21.82	2.27	10.14
CFO/CapEx	3.78	4.4	2.42	2.17	0.24	3.64	1.14	2.87	6.62	6.66	0.94	0.72	7.85	0.54	5.35
Altman's Z-Score	2.85	3.16	2.57	3.36	1.42	1.28	1.64	0.73	0.57	0.54	1.95	-0.17	1.21	-1.82	-2.63

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	7.13	7.55	7.45	7.24	6.45	6.28	5.31	6.93	5.51	5.31	6.01	5.88	6.84	6.08	5.6
Days Sales Outstanding	51.16	48.32	49.01	50.43	56.58	58.13	68.67	52.65	66.24	68.76	60.78	62.06	53.33	60.03	65.17
Inventory Turnover	3.45	3.28	3.43	3.27	2.8	2.65	2.08	2.75	2.2	1.99	2.06	1.94	1.81	1.64	1.66
Days Inventory Outstanding	105.73	111.43	106.5	111.7	130.54	137.59	175.66	132.88	165.94	183.59	177.5	187.75	202.17	222.33	219.41
Accounts Payable Turnover	12.35	12.12	11.85	11.68	8.19	7.17	6.62	11.19	7.69	7.83	10.4	9.05	7.41	7.33	8.11
Accounts Payable Turnover Days	29.56	30.1	30.79	31.26	44.55	50.89	55.1	32.63	47.46	46.64	35.11	40.35	49.27	49.8	45.03
Cash Conversion Cycle	127.33	129.65	124.71	130.87	142.56	144.83	189.23	152.91	184.72	205.72	203.18	209.45	206.23	232.56	239.55
Inventory to Cash Days	-54.57	-63.11	-57.49	-61.28	-73.96	-79.45	-106.98	-80.23	-99.7	-114.83	-116.72	-125.69	-148.83	-162.3	-154.23
Inventories	18	18	16	21	22	20	17	25	22	22	28	26	25	23	21
Raw Materials	9	9	8	9	10	10	10	14	13	14	19	17	15	15	12
Work In Process	1	1	1	1	1	1	1	4	3	4	3	4	4	3	3
Finished Goods	8	8	7	10	11	9	6	7	6	5	6	5	5	5	5
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	84	96	143	182	117	104	115	116	115	166	284	115	227	92	30
- Cash & Cash Equivalents	18	21	26	14	7	6	5	8	8	8	8	5	4	4	9
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	16	13	25	21	19	14	12	61	64	58	57	54	43	44	44
Enterprise Value	83	89	142	190	129	112	121	169	171	215	334	164	265	132	65
Total Capital	-63	-64	-70	-71	-93	-102	-105	-59	-60	-74	-75	-87	-102	-113	-170
Total Debt/Capital (%)	-25.89	-20.25	-35.41	-30.28	-20.24	-13.49	-11.21	-103.64	-108.03	-77.48	-75.68	-61.99	-41.77	-39.35	-26.05
Total Debt / EV	0.2	0.15	0.17	0.11	0.15	0.12	0.1	0.36	0.38	0.27	0.17	0.33	0.16	0.34	0.68
EV/Sales	0.76	0.8	1.35	1.75	1.18	1.08	1.57	1.4	1.48	2.11	2.81	1.45	2.36	1.4	0.76
EV/EBITDA	6.26	7.19	18.47	17.71	35.24	35.84	38.29	19.07	17.92	27.38	34.43	402.07	29.85	139.8	10.81
EV/EBIT	9.31	10.9	38.46	27.76	- -	- -	- -	171.28	93.34	973.07	161.45	- -	140.15	- -	653.61
EV/Cash Flow to Firm	11.43	10.51	25.11	38.89	24.87	17.92	75.52	29.17	13.55	14.83	75.3	43.35	14.1	25.43	5.64
EV/Free Cash Flow to Firm	9.19	8.64	19.35	27.56	15.78	14.5	47.84	24.85	12.36	13.52	57.76	30.55	12.88	16.86	5.09
Diluted Market Cap	88	100	150	188	117	104	115	116	115	166	284	115	227	92	30
Diluted Enterprise Value	87	92	149	196	129	112	121	169	171	215	334	164	265	132	65
EV per Share	29.03	30.82	46.66	58.97	38.27	32.88	34.89	46.24	45.34	55.65	82.68	39.71	62.57	30.38	14.72
TTM Sales	109	111	105	109	109	105	77	121	116	102	119	113	112	94	87
TTM EBITDA	13	12	8	11	4	3	3	9	10	8	10	- -	9	1	6
TTM Operating Income	9	8	4	7	-1	-1	-1	1	2	- -	2	-7	2	-6	- -
TTM Cash Flow to Firm	7	8	6	5	5	6	2	6	13	15	4	4	19	5	12
TTM Free Cash Flow to Firm	9	10	7	7	8	8	3	7	14	16	6	5	21	8	13

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	10.5	10.09	26.14	29.65	31.65	15.21	57.75	29.8	12.45	15.44	109.1	41.84	14.35	22.49	3.72
EV/EBIT	9.31	10.9	38.46	27.76	- -	- -	- -	171.28	93.34	973.07	161.45	- -	140.15	- -	653.61
Enterprise Value	83	89	142	190	129	112	121	169	171	215	334	164	265	132	65
Low Price	29.1	26.3	31.9	36.8	27.3	22.5	22.5	29.6	15.1	13.9	38.7	19.8	24.2	19.5	2.81
EV/Sales	0.76	0.8	1.35	1.75	1.18	1.08	1.57	1.4	1.48	2.11	2.81	1.45	2.36	1.4	0.76
EV/EBITDA	6.26	7.19	18.47	17.71	35.24	35.84	38.29	19.07	17.92	27.38	34.43	402.07	29.85	139.8	10.81
Price/Earnings	22.09	40.71	- -	77.46	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	27.08	36.86	-67.31	61.89	-8.42	-22.52	-117.41	-59.8	-23.98	-15.48	-948.77	-17.57	-54.62	-11.57	-0.54
Price/Earnings High	35.68	43.62	-85.51	81.01	-12.07	-30.98	-156.69	-83.58	-37.6	-22.66	-1,225.7	-31.29	-78.13	-19.09	-1.79
Price/Earnings Low	21.72	31.96	-52.96	50.27	-4.82	-17.87	-90.4	-36.93	-12.18	-6.88	-542.11	-8.62	-30.06	-6.84	-0.22
Price/Book Value	-1.06	-1.25	-1.51	-1.98	-1.05	-0.9	-0.98	-0.97	-0.93	-1.26	-2.15	-0.81	-1.56	-0.58	-0.14
Price/Book Value Average	-1.3	-1.14	-1.3	-1.58	-1.44	-0.84	-0.87	-1.46	-0.91	-0.92	-2.07	-1.18	-1.28	-0.91	-0.14
Price/Book Value High	-1.72	-1.34	-1.65	-2.07	-2.06	-1.15	-1.16	-2.04	-1.42	-1.34	-2.67	-2.1	-1.84	-1.5	-0.47
Price/Book Value Low	-1.04	-0.99	-1.02	-1.28	-0.82	-0.67	-0.67	-0.9	-0.46	-0.41	-1.18	-0.58	-0.71	-0.54	-0.06
Price/Tangible Book Value	2.24	2.12	3.8	5.49	7.7	6.74	3.45	-5.7	-8.18	-11.01	-170	-22.7	-8,405.44	-22.32	-8.57
Price/Tangible Book Value Average	2.74	1.92	3.28	4.38	10.59	6.26	3.05	-8.59	-7.97	-8.03	-163.33	-33.09	-6,907.92	-34.87	-8.77
Price/Tangible Book Value High	3.61	2.27	4.16	5.74	15.17	8.62	4.07	-12.01	-12.5	-11.75	-211	-58.92	-9,882.29	-57.54	-29.22
Price/Tangible Book Value Low	2.2	1.66	2.58	3.56	6.05	4.97	2.35	-5.3	-4.05	-3.57	-93.32	-16.22	-3,802.09	-20.63	-3.6
Price/Sales	0.77	0.87	1.36	1.68	1.07	1	1.48	0.96	0.99	1.62	2.39	1.01	2.02	0.98	0.34
Price/Sales Average	0.95	0.79	1.17	1.34	1.48	0.93	1.31	1.45	0.97	1.18	2.3	1.48	1.66	1.52	0.35
Price/Sales High	1.25	0.93	1.49	1.76	2.11	1.28	1.75	2.02	1.52	1.73	2.97	2.63	2.38	2.52	1.17
Price/Sales Low	0.76	0.68	0.92	1.09	0.84	0.74	1.01	0.89	0.49	0.53	1.31	0.72	0.91	0.9	0.14
Price/Cash Flow	12.67	11.97	35.17	41.92	165.34	19.38	108.5	40.19	14.34	17.77	225.37	99.58	16.18	63.8	4.41
Price/Cash Flow Average	15.53	10.84	30.34	33.5	227.44	18.02	96.08	60.59	13.97	12.96	216.52	145.16	13.3	99.68	4.51
Price/Cash Flow High	20.46	12.82	38.54	43.85	325.92	24.79	128.23	84.69	21.9	18.97	279.72	258.47	19.02	164.48	15.04
Price/Cash Flow Low	12.45	9.39	23.87	27.21	130.08	14.3	73.98	37.41	7.1	5.76	123.71	71.18	7.32	58.96	1.85
Price/Free Cash Flow Average	12.87	9.14	22.54	23.69	43.54	14.14	51.14	44.92	12.13	11.27	104.81	60.99	11.79	35.15	3.8
Price/Free Cash Flow High	16.96	10.81	28.64	31.01	62.39	19.44	68.25	62.79	19.03	16.49	135.41	108.59	16.87	57.99	12.67
Price/Free Cash Flow Low	10.32	7.92	17.74	19.24	24.9	11.22	39.37	27.74	6.17	5	59.89	29.9	6.49	20.79	1.56
EV/Sales Average	0.93	0.72	1.16	1.41	1.59	1.01	1.4	1.88	1.45	1.67	2.71	1.91	2	1.95	0.76
EV/Sales High	1.23	0.86	1.48	1.82	2.22	1.35	1.84	2.46	2	2.22	3.38	3.07	2.72	2.95	1.58
EV/Sales Low	0.75	0.61	0.91	1.16	0.95	0.81	1.09	1.33	0.97	1.01	1.73	1.16	1.26	1.33	0.56
EV/EBITDA Average	7.7	6.45	15.91	14.29	47.24	33.5	34.15	25.73	17.61	21.67	33.28	530.47	25.3	194.42	10.92
EV/EBITDA High	10.18	7.75	20.25	18.49	66.27	45.1	44.88	33.59	24.28	28.81	41.51	849.61	34.34	293.06	22.64
EV/EBITDA Low	6.15	5.51	12.49	11.73	28.43	27.12	26.77	18.16	11.83	13.11	21.19	322.08	15.87	132.44	7.96
EV/EBIT Average	11.45	9.78	33.13	22.39	-186.31	-92.64	-170.26	231.06	91.73	770.19	156.04	-30.28	118.8	-29.61	660.35
EV/EBIT High	15.15	11.75	42.16	28.98	-261.37	-124.74	-223.77	301.68	126.48	1,023.77	194.65	-48.49	161.2	-44.64	1,368.74
EV/EBIT Low	9.15	8.36	26.01	18.39	-112.11	-75	-133.46	163.13	61.64	466.03	99.35	-18.38	74.52	-20.17	481.37
Last Price	29.6	33.5	47	56.7	34.7	30.5	33	31.8	30.5	42.9	70.5	27.7	53.5	21.1	6.69
High Price	47.8	35.9	51.5	59.3	68.4	39	39	67	46.6	45.8	87.5	71.9	62.9	54.4	22.8
Enterprise Value Average	102	80	122	153	172	105	108	227	169	170	322	217	225	184	66
Enterprise Value High	134	96	155	198	242	142	142	297	232	226	402	347	305	277	137
Enterprise Value Low	81	68	96	126	104	85	85	161	113	103	205	132	141	125	48

Shares Outstanding	3	3	3	3	3	3	4	4	4	4	4	4	4	4	4
Diluted Weighted Avg Shares	3	3	3	3	3	3	3	4	4	4	4	4	4	4	4
Basic Weighted Avg Shares	3	3	3	3	3	3	3	4	4	4	4	4	4	4	4
Revenue per Share	38.26	38.6	34.61	33.78	32.35	30.55	22.27	33.13	30.72	26.42	29.47	27.37	26.46	21.62	19.5
EBITDA per Share	4.64	4.29	2.53	3.33	1.09	0.92	0.91	2.42	2.53	2.03	2.4	0.1	2.1	0.22	1.36
Operating Income per Share	3.12	2.83	1.21	2.12	-0.28	-0.33	-0.18	0.27	0.49	0.06	0.51	-1.73	0.45	-1.43	0.02
Basic EPS, GAAP	1.34	0.82	-0.6	0.73	-5.67	-1.26	-0.25	-0.8	-1.24	-2.02	-0.07	-2.3	-0.81	-2.85	-12.77
Basic EPS from Cont Ops	1.86	1.56	0.24	0.73	-5.67	-1.26	-0.58	-1.18	-1.24	-2.02	-0.07	-2.3	-0.81	-2.85	-12.77
Diluted EPS, GAAP	1.28	0.8	-0.57	0.71	-5.67	-1.26	-0.25	-0.8	-1.24	-2.02	-0.07	-2.3	-0.81	-2.85	-12.77
Diluted EPS from Cont Ops	1.77	1.51	0.23	0.71	-5.67	-1.26	-0.58	-1.18	-1.24	-2.02	-0.07	-2.3	-0.81	-2.85	-12.77
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	2.34	2.8	1.34	1.35	0.21	1.57	0.3	0.79	2.13	2.41	0.31	0.28	3.31	0.33	1.52
Free Cash Flow per Basic Share	1.72	2.16	0.78	0.73	-0.68	1.14	0.04	0.52	1.81	2.05	-0.02	-0.11	2.89	-0.28	1.23
Cash & Equivalents per Share	6.3	7.18	8.48	4.39	2.01	1.64	1.49	2.24	2.2	2.15	1.94	1.09	1.01	0.94	1.94
Book Value per Share	-27.86	-26.7	-31.15	-28.69	-33.13	-33.79	-33.54	-32.77	-32.83	-34.15	-32.77	-34.23	-34.22	-36.19	-48.27
Tangible Book Value per Share	13.23	15.8	12.37	10.33	4.51	4.53	9.58	-5.58	-3.73	-3.9	-0.41	-1.22	-0.01	-0.95	-0.78

Harvard Bioscience, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)